Mobile Health App for Breast Cancer

Recruiting in Palo Alto (17 mi)

Overseen by Marjory Charlot, MD, MPH, MSc

Age: 18+

Sex: Female

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: UNC Lineberger Comprehensive Cancer Center

Disqualifiers: Dementia, Psychiatric condition, others

No Placebo Group

Approved in 1 Jurisdiction

Trial Summary

What is the purpose of this trial?

This study explores the overall feasibility, impact, and satisfaction of using the "mHealth app" on clinic workflow for Black or African American women diagnosed with breast cancer. The "mHealth app" which can be used as a platform to share clinical trial education and communication, was created and tested in previous steps of this study.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the Mobile Health App for Breast Cancer treatment?

Research shows that mobile health apps can help breast cancer patients by providing timely information, tracking symptoms, and encouraging healthy behaviors like physical activity, which can improve quality of life and reduce cancer recurrence. These apps have been shown to have high usage rates and can enhance self-management and adherence to treatment plans. ^{1 2 3 4 5}

Is the Mobile Health App for Breast Cancer safe for humans?

The research indicates that mobile health apps for breast cancer patients are generally safe, as they focus on monitoring symptoms, improving treatment adherence, and enhancing communication with doctors. No specific safety concerns were reported in the studies reviewed. ^{4 6 7 8 9}

How does the Mobile Health App for Breast Cancer differ from other treatments?

The Mobile Health App for Breast Cancer is unique because it uses smartphone technology to provide information, track symptoms, and support mental well-being, which is different from traditional treatments like surgery or chemotherapy that focus on physically treating the cancer itself. ^{2 10 11 12 13}

Research Team

Marjory Charlot, MD, MPH, MSc

Principal Investigator

UNC Lineberger Comprehensive Cancer Center

Eligibility Criteria

This trial is specifically for Black or African American women who have been diagnosed with breast cancer. It aims to understand how a mobile health app can fit into clinical settings and help these women learn about and participate in breast cancer trials.

Inclusion Criteria

Identify as African American

I am 18 years old or older.

Have access to a mobile device or computer

Exclusion Criteria

I am mentally capable of understanding and giving informed consent.

Inability to read and speak English

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive access to the mHealth app and a list of available clinical trials, along with standard care resources

Up to 1 year

Follow-up

Participants are monitored for feasibility and satisfaction with the mHealth app

Up to 1 year

Treatment Details

Interventions

• mHealth app (Behavioral Intervention)

Trial Overview The study is testing the 'mHealth app,' which provides educational resources and communication tools about breast cancer clinical trials. The focus is on its practicality, effect on clinic operations, and user satisfaction among participants.

Participant Groups

Group I: mHealth app Experimental Treatment 2 Interventions

Women enrolled in the mHealth app study will receive access to the "mHealth" app, a list of available clinical trials within a 50-mile radius of their zip code, and the existing standard of care packet of cancer center resources.

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

UNC Lineberger Comprehensive Cancer Center Chapel Hill, NC

Who Is Running the Clinical Trial?

UNC Lineberger Comprehensive Cancer Center

Lead Sponsor

Trials

377

Patients Recruited

95,900+

Conquer Cancer Foundation

Collaborator

Trials

22

Patients Recruited

4,000+

Findings from Research

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Use of Evidence-Based Best Practices and Behavior Change Techniques in Breast Cancer Apps: Systematic Analysis. Kalke, K., Ginossar, T., Bentley, JM., et al.[2021]

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

A Mobile App (AMOR Mama) for Women With Breast Cancer Undergoing Radiation Therapy: Functionality and Usability Study. Cruz, FOAMD., Faria, ET., Ghobad, PC., et al.[2021]

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Mobile applications for early breast cancer chemotherapy-related symptoms reporting and management: A scoping review. Suchodolska, G., Senkus, E.[2022]

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Mobile Physical Activity Intervention for Breast Cancer Patients During Chemotherapy. Geng, Z., Wu, F., Zhang, Y., et al.[2018]

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

A Scoping Review and a Taxonomy to Assess the Impact of Mobile Apps on Cancer Care Management. Dhar, E., Bah, AN., Chicchi Giglioli, IA., et al.[2023]

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

A Mobile App to Stabilize Daily Functional Activity of Breast Cancer Patients in Collaboration With the Physician: A Randomized Controlled Clinical Trial. Egbring, M., Far, E., Roos, M., et al.[2022]

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Impact of web application support versus standard management on adherence with adjuvant hormone therapy in patients treated for breast cancer: the WEBAPPAC study. Gernier, F., Grellard, JM., Dupont, C., et al.[2023]

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

mHealth Technology as a Help Tool during Breast Cancer Treatment: A Content Focus Group. Fuentes, A., Amat, C., Lozano-Rubí, R., et al.[2023]

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Mobile Applications Available in Germany Supporting Breast Cancer Patients During Treatment and Aftercare: a Systematic Review. Gomm, SIM., Ebner, FK., Lukac, S., et al.[2023]

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

A biopsy of Breast Cancer mobile applications: state of the practice review. Giunti, G., Giunta, DH., Guisado-Fernandez, E., et al.[2022]

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Content, Usability, and Utilization of Plain Language in Breast Cancer Mobile Phone Apps: A Systematic Analysis. Ginossar, T., Shah, SF., West, AJ., et al.[2023]

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Mobile health applications for the care of patients with breast cancer: A scoping review. Cai, T., Huang, Y., Zhang, Y., et al.[2022]

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Development, usability and quality evaluation of the resilient mobile application for women with breast cancer. Rezaee, R., Asadi, S., Yazdani, A., et al.[2022]

References

1. Canada pubmed.ncbi.nlm.nih.gov

Use of Evidence-Based Best Practices and Behavior Change Techniques in Breast Cancer Apps: Systematic Analysis. [2021]

2. Canada pubmed.ncbi.nlm.nih.gov

A Mobile App (AMOR Mama) for Women With Breast Cancer Undergoing Radiation Therapy: Functionality and Usability Study. [2021]

3. Netherlands pubmed.ncbi.nlm.nih.gov

Mobile applications for early breast cancer chemotherapy-related symptoms reporting and management: A scoping review. [2022]

4. Netherlands pubmed.ncbi.nlm.nih.gov

Mobile Physical Activity Intervention for Breast Cancer Patients During Chemotherapy. [2018]

5. Switzerland pubmed.ncbi.nlm.nih.gov

A Scoping Review and a Taxonomy to Assess the Impact of Mobile Apps on Cancer Care Management. [2023]

6. Canada pubmed.ncbi.nlm.nih.gov

A Mobile App to Stabilize Daily Functional Activity of Breast Cancer Patients in Collaboration With the Physician: A Randomized Controlled Clinical Trial. [2022]

7. England pubmed.ncbi.nlm.nih.gov

Impact of web application support versus standard management on adherence with adjuvant hormone therapy in patients treated for breast cancer: the WEBAPPAC study. [2023]

8. Switzerland pubmed.ncbi.nlm.nih.gov

mHealth Technology as a Help Tool during Breast Cancer Treatment: A Content Focus Group. [2023]

9. Germany pubmed.ncbi.nlm.nih.gov

Mobile Applications Available in Germany Supporting Breast Cancer Patients During Treatment and Aftercare: a Systematic Review. [2023]

10. Ireland pubmed.ncbi.nlm.nih.gov

A biopsy of Breast Cancer mobile applications: state of the practice review. [2022]

11. Canada pubmed.ncbi.nlm.nih.gov

Content, Usability, and Utilization of Plain Language in Breast Cancer Mobile Phone Apps: A Systematic Analysis. [2023]

12. China pubmed.ncbi.nlm.nih.gov

Mobile health applications for the care of patients with breast cancer: A scoping review. [2022]

13. United States pubmed.ncbi.nlm.nih.gov

Development, usability and quality evaluation of the resilient mobile application for women with breast cancer. [2022]